logo-horizontal-main.png
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
November 12, 2024 16:05 ET | OncoCyte Corporation
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
logo-horizontal-main.png
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
November 06, 2024 16:45 ET | OncoCyte Corporation
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
Head and Neck Cancer Diagnostics Market
Head and Neck Cancer Diagnostics Market Research Report 2023-2030: Increasing Focus on Personalized Medicine, Targeted Therapies, Liquid Biopsy and Molecular Testing Expands Opportunities
November 04, 2024 11:16 ET | Research and Markets
Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Head and Neck Cancer Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
logo-horizontal-main.png
Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial
October 08, 2024 08:30 ET | OncoCyte Corporation
Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to benefit from atezolizumab DetermaIO...
logo-horizontal-main.png
Oncocyte Signs Leading Transplant Centers in US and Germany
October 02, 2024 18:41 ET | OncoCyte Corporation
GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volumeCompany clears first stage gate in clinical product development process and has...
22157.jpg
Growth Opportunities in the Tissue Diagnostics Industry 2024-2029: Multiomics Analysis for Precision Diagnostics, Comprehensive Diagnostic Panels for Early Identification of Cancer Biomarkers
October 02, 2024 07:04 ET | Research and Markets
Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024-2029" report has been added to ResearchAndMarkets.com's offering.The global...
SNS-INSIDER-300X300.jpg
Precision Diagnostics Market Size Expected to Reach USD 224.53 Billion by 2032 with a CAGR of 13.50% - SNS Insider
September 24, 2024 09:00 ET | SNS Insider pvt ltd
Pune, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Precision Diagnostics Market Size & Growth Analysis: The Precision Diagnostics Market size was valued at USD 75.87 billion in 2023 and is projected to...
Preeclampsia Diagnostics Market
Preeclampsia Diagnostics Market Projected to Reach $1.211 Billion by 2029: Efforts to Boost Awareness and Diagnostic Accessibility Boosts Expansion
August 16, 2024 07:20 ET | Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Preeclampsia Diagnostics Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. The prevalence of...
logo-horizontal-main.png
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
August 12, 2024 16:10 ET | OncoCyte Corporation
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Beta Costumer Revenue Path
Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results
August 08, 2024 16:05 ET | OncoCyte Corporation
Oncocyte Announces Successful GraftAssureTM Beta Launch and Q2 2024 Results